Society for Cardiovascular Angiography Interventions (SCAI)

The Society for Cardiovascular Angiography and Interventions (SCAI) represents interventional cardiology through education, advocacy, research, setting guidelines and quality patient care. SCAI provides thought leadership in cath lab procedures, new technology and policy.

New SCAI President Dawn Abbott outlines workforce training and inclusion priorities
SCAI President Dawn Abbott, MD, MSCAI, aims to turn attention toward the long-term sustainability of the interventional cardiology field.
Fewer stents, positive outcomes: Sirolimus-eluting balloons a safe alternative during PCI
Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.
Popular weight loss drug linked to key benefits for patients undergoing TAVR, PCI
Two separate studies explored the value of treating heart patients with tirzepatide.
Sirolimus- and paclitaxel-coated balloons deliver comparable 1-year PCI outcomes
Researchers explored data from more than 8,000 patients treated over a three-year period.
Outgoing SCAI president reflects on a busy year full of partnerships and advocacy
SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, made a major impact on the group—and cardiology as a whole—over the last 12 months.

The Society for Cardiovascular Angiography and Interventions (SCAI) is entering a new chapter as Dawn Abbott, MD, MSCAI, who assumeed the presidency this week with a focus on strengthening the future of interventional cardiology through workforce development, expanded training pathways and continued efforts to broaden inclusion in the specialty. #SCAI2026 #SCAI26

New SCAI President Dawn Abbott outlines workforce training and inclusion priorities

SCAI President Dawn Abbott, MD, MSCAI, aims to turn attention toward the long-term sustainability of the interventional cardiology field.

Cordis acquires MedAlliance, known for its drug-eluting balloon technology, in deal that could surpass $1B

Fewer stents, positive outcomes: Sirolimus-eluting balloons a safe alternative during PCI

Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.

heart data research doctor cardiologist AI

Two separate studies explored the value of treating heart patients with tirzepatide.

cardiologists going through the certification process

Sirolimus- and paclitaxel-coated balloons deliver comparable 1-year PCI outcomes

Researchers explored data from more than 8,000 patients treated over a three-year period.

Video interview with Society for Cardiovascular Angiography and Interventions (SCAI) President Srihari S. Naidu, MD, FACC, FAHA, MSCAI, explains the advancements in interventional cardiology the society has championed over the past year. #SCAI

Outgoing SCAI president reflects on a busy year full of partnerships and advocacy

SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, made a major impact on the group—and cardiology as a whole—over the last 12 months.

heart doctors and surgeons working together. top cardiology hospitals in the United States.

Cardiologists lead push for new cath lab radiation safety standards

Several U.S. medical societies have collaborated on a new report advocating for better safety standards in cardiac catheterization labs. As one cardiologist described it, clinicians have shifted from "accepting risk" to "expecting better."

Amir Lerman, MD, a veteran cardiologist with Mayo Clinic, died unexpectedly on Feb. 23. He was 69 years old.

Pioneer cardiologist Amir Lerman remembered as a ‘true giant’ of the specialty

Lerman, who spent nearly 40 years with Mayo Clinic, was especially influential in the treatment of nonobstructive CAD.

Several interventional cardiology late-breaking studies were presented at the Cardiovascular Research Technologies (CRT) 2026 meeting March 7-10, and experts from the Society of Society highlighted what they felt was most impactful to clinical practice. Photo by Dave Fornell.

CRT 2026: Key takeaways for interventional cardiologists

CRT studies shed new light on many topics, including long-term TAVR outcomes, radiation protection and advanced interventional techniques.